Revelation Biosciences In... (REVB)
NASDAQ: REVB
· Real-Time Price · USD
3.20
0.10 (3.38%)
At close: May 09, 2025, 3:33 PM
3.25
1.56%
After-hours: May 09, 2025, 05:41 PM EDT
3.38% (1D)
| Bid | 3.06 |
| Market Cap | 2.9M |
| Revenue (ttm) | 26.96K |
| Net Income (ttm) | -15.04M |
| EPS (ttm) | -87.68 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | -1.1 |
| Analyst | n/a |
| Ask | 3.25 |
| Volume | 23,721 |
| Avg. Volume (20D) | 120,449 |
| Open | 3.04 |
| Previous Close | 3.10 |
| Day's Range | 3.06 - 3.21 |
| 52-Week Range | 2.36 - 60.80 |
| Beta | 0.19 |
About REVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol REVB
Website n/a
3 months ago
-23.84%
Revelation Biosciences shares are trading lower af...
Unlock content with
Pro Subscription
5 months ago
+25%
Revelation Biosciences shares are trading higher after the company announced FDA acceptance of Gemini IND.
1 month ago · businesswire.com
Revelation Biosciences to Host Fireside Chat at 37th Annual Roth ConferenceSAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammati...
2 months ago · businesswire.com
Revelation Biosciences, Inc. Receives Continued NASDAQ Listing ApprovalSAN DIEGO--(BUSINESS WIRE)---- $REVB #GEMINI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflamm...